EnceladusMed AB

Active
559077-0342Limited company (AB)Registered 2016STOCKHOLM

Key figures

0 kr−100,0%
Revenue 2025
0500 k1 m1,5 m2019202020212022202320242025

Key figures

2025

Summary: EnceladusMed AB

What kind of company is it?

EnceladusMed AB (org. no. 559077-0342) is a limited company (AB). The company was registered in 2016 and has existed for 10 years. Registered seat: Stockholm. Industry according to Statistics Sweden: other general medical practice activities (SNI 86212).

How is the company doing financially?

The company had no net sales in financial year 2025. Net profit for 2025 was 123 497 kr. The company was profitable in all 7 reported financial years. At the end of financial year 2025, total assets were 3 007 156 kr and equity 1 961 214 kr (equity ratio 65,2 %). The annual report for 2025 proposes a dividend of 322 400 kr.

Where does the data come from and how up to date is it?

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Dividend

from the annual report
2025

Proposed dividend 322 400 kr.

History
2025322 400 kr
2024209 700 kr
2023206 000 kr
2021187 000 kr
2020185 000 kr
Summary of annual reports2019–2025
20212022202320242025
Sales revenue1 032 436986 702872 298774 7990
Profit for the reporting year445 443341 428426 715418 364123 497
Retained earnings of previous periods—————
Total assets2 711 8342 965 4073 201 1113 398 4663 007 156
Total liabilities1 262 9231 362 0681 366 0581 351 0481 045 942
Total equity1 448 9111 603 3391 835 0532 047 4181 961 214
Employees—————
Proposed dividend187 000—206 000209 700322 400

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.